NinaBhardwajMD

Rheumatology • New York, NY

Professor, Medicine, New York University School of Medicine

Join to view full profile

Dr. Bhardwaj is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bhardwaj's full profile

Already have an account?

Office
522 1st Ave
New York, NY 10016
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 1986 - 1987
Brigham and Women's HospitalResidency, Internal Medicine, 1981 - 1983
New York University School of MedicineClass of 1981

Certifications & Licensure

NY State Medical License 1983 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1999

Clinical Trials

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients Start of enrollment: 2000 Nov 01
Completed
Phase 1
Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine Start of enrollment: 2005 Jul 01
Completed
Phase 1
NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting) Start of enrollment: 2005 Aug 24
Completed
Phase 1
NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors Start of enrollment: 2006 Mar 21
Completed
Phase 1
Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination Start of enrollment: 2009 Feb 01
Completed
Phase 1
Safety Study of Adjuvant Vaccine to Treat Melanoma Patients Start of enrollment: 2010 Sep 01
Completed
Phase 1, Phase 2
CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma Start of enrollment: 2012 Oct 01
Terminated
Phase 2
PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2014 Jan 01
Terminated
Not Applicable
A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma Start of enrollment: 2014 Apr 09
Completed
Phase 2
In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® Start of enrollment: 2015 Mar 01
Completed
Phase 2
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers Start of enrollment: 2016 Dec 28
Completed
Phase 1, Phase 2
Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies Start of enrollment: 2016 Apr 01
Completed
Phase 1
Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1 Start of enrollment: 2018 Sep 25
Terminated
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

22 citations
Lung Cancer and SARS-CoV-2 infection: Identifying important knowledge gaps for investigation.
Christian Rolfo, Noy Meshulami, Alessandro Russo, Florian Krammer, Adolfo García-Sastre, Philip C. Mack, Jorge Gomez, Nina Bhardwaj, Amin Benyounes, Rafael Sirera, Amy...> ;Journal of Thoracic Oncology. 2021 Nov 10
16 citations
New interpretable machine learning method for single-cell data reveals correlates of clinical response to cancer immunotherapy
Evan Greene, Greg Finak, Leonard A D'Amico, Nina Bhardwaj, Candice D. Church, Chihiro Morishima, Nirasha Ramchurren, Janis M. Taube, Paul Nghiem, Martin A. Cheever, St...> ;Patterns. 2021 Oct 27
54 citations
Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma.
Adolfo Aleman, Bhaskar Upadhyaya, Kevin Tuballes, Katerina Kappes, Charles R Gleason, Katherine Beach, Sarita Agte, Komal Srivastava, Pvi, Oliver Van Oekelen, Vanessa ...> ;Cancer Cell. 2021 Oct 19
Martin A. "Mac" Cheever, MD: In Memoriam (1944-2021).
Olivera J. Finn, Nina Bhardwaj, Steven P. Fling, Judith C Kaiser> ;Cancer immunology research. 2021 Oct 13
9 citations
PD-1 inhibition in advanced myeloproliferative neoplasms.
Gabriela S. Hobbs, Cansu Cimen Bozkus, Erin Moshier, Mikeaela Dougherty, Michal Bar-Natan, Lonette Sandy, Kathryn Johnson, Julia Foster, Tina T. Som, Molly Macrae, Het...> ;Blood Advances. 2021 Sep 28
2 citations
Tumor organoid-originated biomarkers predict immune response to PD-1 blockade
Cansu Cimen Bozkus, Nina Bhardwaj> ;Cancer Cell. 2021 Sep 13
11 citations
A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses.
Cansu Cimen Bozkus, Ana Belen Blazquez, Tomohiro Enokida, Nina Bhardwaj> ;STAR Protocols. 2021 Aug 17
22 citations
MMP2 and TLRs modulate immune responses in the tumor microenvironment
Luciana Rebiero Muniz-Bongers, Christopher B. McClain, Mansi Saxena, Gerold Bongers, Miriam Merad, Nina Bhardwaj> ;JCI Insight. 2021 Jun 22
50 citations
Innate immune cells in the tumor microenvironment.
Ming O. Li, Natalie K. Wolf, David H. Raulet, Leila Akkari, Mikael J. Pittet, Paulo C. Rodriguez, Rosandra N. Kaplan, Ariel Munitz, Zemin Zhang, Sijin Cheng, Nina Bhar...> ;Cancer Cell. 2021 Jun 14
81 citations
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.
Shira Weingarten-Gabbay, Susan Klaeger, Siranush Sarkizova, Leah R. Pearlman, Da Yuan Chen, Kathleen Gallagher, Matthew R. Bauer, Hannah B. Taylor, W. Augustine Dunn, ...> ;Cell. 2021 Jul 22
30 citations
Vaccines for immunoprevention of cancer
Tomohiro Enokida, Alvaro Moreira, Nina Bhardwaj> ;The Journal of Clinical Investigation. 2021 May 3
405 citations
Therapeutic cancer vaccines.
Mansi Saxena, Sjoerd H van der Burg, Cornelis J M Melief, Nina Bhardwaj> ;Nature Reviews. Cancer. 2021 Jun 1
15 citations
Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing
Li Wang, John P. Sfakianos, Kristin G. Beaumont, Guray Akturk, Amir Horowitz, Robert Sebra, Adam M. Farkas, Sacha Gnjatic, Austin Hake, Sudeh Izadmehr, Peter Wiklund, ...> ;Clinical Cancer Research. 2021 Aug 1
Uncloaking Breast Tumor Neoantigens with Radiation
Jenna H. Newman, Nina Bhardwaj> ;Trends in Immunology. 2021 Mar 3
28 citations
Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer.
John P. Sfakianos, Bérengère Salomé, Jorge Daza, Adam M. Farkas, Nina Bhardwaj, Amir Horowitz> ;Urologic Oncology. 2021 Feb 1
32 citations
CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model.
I-Li Tan, Raquel Duque Nascimento Arifa, Harikrishna Rallapalli, Veronika Kana, Zhimin Lao, Reeti Mayur Sanghrajka, N. Sumru Bayin, Antoine Tanne, Alexandre Wojcinski,...> ;Oncogene. 2021 Jan 14
9 citations
Super(antigen) target for SARS-CoV-2.
Matthew Brown, Nina Bhardwaj> ;Nature Reviews. Immunology. 2021 Feb 1
32 citations
Current Melanoma Treatments: Where Do We Stand?
Alvaro Moreira, Lucie Heinzerling, Nina Bhardwaj, Philip Friedlander> ;Cancers. 2021 Jan 9
27 citations
Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer Vaccines.
Vladimir Roudko, Cansu Cimen Bozkus, Benjamin D. Greenbaum, Aimee L. Lucas, Robert M. Samstein, Nina Bhardwaj> ;Frontiers in Immunology. 2021 Jan 1
91 citations
Intravenous nanoparticle vaccination generates stem-like TCF1 + neoantigen-specific CD8 + T cells
Faezzah Baharom, Ramiro A. Ramirez-Valdez, Kennedy Tobin, Hidehiro Yamane, Charles-Antoine Dutertre, Ahad Khalilnezhad, Glennys V. Reynoso, Vincent L. Coble, Geoffrey ...> ;Nature Immunology. 2021 Jan 1
80 citations
Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors.
Vladimir Roudko, Cansu Cimen Bozkus, Theofano Orfanelli, Christopher B. McClain, Caitlin Carr, Timothy O'Donnell, Lauren Chakraborty, Robert M. Samstein, Kuan-lin Huan...> ;Cell. 2020 Dec 10
31 citations
Landscape of natural killer cell activity in head and neck squamous cell carcinoma.
Andrew Charap, Tomohiro Enokida, Rachel Brody, John P. Sfakianos, Brett A. Miles, Nina Bhardwaj, Amir Horowitz> ;Journal for Immunotherapy of Cancer. 2020 Dec 1
52 citations
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets
Nina Bhardwaj, Philip Friedlander, Anna C. Pavlick, Marc S. Ernstoff, Brian R. Gastman, Brent A. Hanks, Brendan D. Curti, Mark R. Albertini, Jason J. Luke, Ana Belen B...> ;Nature Cancer. 2020 Nov 16
12 citations
Unexplored horizons of cDC1 in immunity and tolerance.
Sreekumar Balan, Kristen J. Radford, Nina Bhardwaj> ;Advances in Immunology. 2020 Nov 1
218 citations
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang, Vanessa M. Hubbard-Lucey, Kathleen C. F. Sheehan, Katie M. Campbell, Andrew Lamb, Jeffrey P. Ward, John Sidney, ...> ;Cell. 2020 Oct 29
Join now to see all

Journal Articles

A Natural Killer–Dendritic Cell Axis Defines Checkpoint Therapy–Responsive Tumor Microenvironments
Patrick K Ha, William R Ryan, Nina Bhardwaj, Vincent Chan, Michael D Alvarado, Adil I Daud, Joy Hsu, Nature